Tympanoplasty / Myringoplasty — Cost, Top Hospitals & Success Rates | MyMedicPlus

Myringoplasty and tympanoplasty are closely related otological procedures performed to reconstruct the tympanic membrane (eardrum) and, where necessary, the middle-ear sound-conducting mechanism. The distinction is clinically important: myringoplasty (Wullstein type I) refers exclusively to repair of a tympanic membrane (TM) perforation when the ossicular chain is intact and mobile, whereas tympanoplasty encompasses repair of the TM together with reconstruction of middle-ear structures, including the ossicles.

TM perforations affect an estimated 1% of the global population and are most commonly caused by chronic suppurative otitis media (CSOM), acute otitis media with rupture, barotrauma, or direct trauma. When a perforation fails to close spontaneously within 3 months, surgical repair is typically considered to restore the acoustic barrier, eliminate recurrent otorrhoea, and improve air-conduction hearing.

The Wullstein classification system (1952, revised) categorises tympanoplasty procedures by the anatomical extent of reconstruction:

• Type I (Myringoplasty): TM repair only; intact, mobile ossicular chain.
• Type II: TM graft placed on a partially eroded incus.
• Type III: TM graft placed directly on a mobile stapes head (myringostapediopexy).
• Type IV: Stapes footplate is mobile; sound shield created over the round window niche.
• Type V: Fenestration of the semicircular canal (rarely performed today).

The most common graft material is temporalis fascia — the thin fibrous sheet overlying the temporal muscle — harvested through the same incision. Other autografts include tragal perichondrium and cartilage (which provides superior rigidity in retraction pockets), and tragal cartilage–perichondrium composite grafts for large or subtotal perforations. The graft can be placed using the underlay technique (medial to the annulus and remnant TM — the current gold standard for most perforations) or the overlay technique (lateral to the annulus — preferred for anterior perforations where visualisation of the annulus is limited).

Eustachian tube (ET) function is a critical determinant of surgical success. Pre-operative ET dysfunction results in negative middle-ear pressure that can cause graft retraction or re-perforation. Surgeons assess ET function clinically, by tympanometry, and occasionally with ET function tests before proceeding. Active infection must be controlled and the ear dry for a minimum of 6–8 weeks prior to surgery.

Tympanoplasty and myringoplasty are indicated for a spectrum of conditions that result in tympanic membrane defects or middle-ear pathology:

• Chronic suppurative otitis media (CSOM) — tubotympanic type: The most common indication worldwide. Characterised by a central (safe) TM perforation with intermittent mucopurulent discharge and conductive hearing loss. The absence of cholesteatoma distinguishes it from the more dangerous atticoantral type.
• Traumatic tympanic membrane perforation: Caused by blast injury, cotton-tipped applicator injury, slap to the ear, barotrauma during diving or air travel, or temporal bone fracture. Most traumatic perforations are posterior or inferior. Up to 90% close spontaneously within 3 months; those persisting beyond this require surgical repair.
• Iatrogenic perforation: Residual perforation following ventilation tube extrusion or failed previous tympanoplasty.
• Atelectatic tympanic membrane: Severe retraction pockets — particularly in the pars tensa or pars flaccida — that have not progressed to cholesteatoma but threaten middle-ear structures.
• Ossicular discontinuity without cholesteatoma: Incus lenticular process erosion from chronic inflammation requiring type II or type III tympanoplasty.
• Recurrent acute otitis media: Where a persistent perforation acts as a recurrent portal of infection and conservative ventilation-tube placement is insufficient.

Pre-operative assessment includes pure-tone audiometry (PTA), tympanometry, and high-resolution CT of the temporal bones if cholesteatoma or ossicular pathology is suspected. Speech discrimination scores help predict functional hearing benefit post-operatively.

Appropriate patient selection is the strongest predictor of successful tympanoplasty outcome. The following criteria guide candidacy assessment:

Favourable Factors (Proceeding with Surgery)

• Dry, infection-free ear for at least 6–8 weeks prior to operation
• Intact and mobile ossicular chain (for myringoplasty/type I)
• Adequate eustachian tube function confirmed clinically or by ET function testing
• Age typically >7 years in children (ET matures and recurrent AOM frequency declines); some centres operate from age 5 with careful selection
• Conductive hearing loss ≥20 dB air-bone gap that adversely affects communication
• Patient motivation and ability to comply with post-operative water precautions

Relative Contraindications

• Only-hearing ear (requires careful risk-benefit discussion)
• Poor ET function with evidence of chronic negative middle-ear pressure
• Active acute infection or otorrhoea at time of planned surgery
• Significant comorbidity increasing anaesthetic risk
• Cholesteatoma present (requires tympanoplasty with mastoidectomy — separate consideration)

Special Populations

In children under 12, success rates are marginally lower (75–85%) compared to adults due to immature ET function and higher rates of upper respiratory tract infection predisposing to middle-ear negative pressure. Many otologists defer surgery until the child has remained infection-free for 12 months. Bilateral perforations may be staged (one ear at a time) to maintain hearing throughout recovery. The contralateral ear should always be examined for coexisting pathology before operating.

Patients with a sensorineural component to their hearing loss should receive pre-operative counselling that surgery corrects only the conductive component and cannot restore sensorineural thresholds.

The surgical approach and graft strategy are individualised according to perforation size, location, middle-ear status, and surgeon experience.

Surgical Approaches

• Transcanal (endaural): Performed entirely through the external auditory canal using an operating microscope or rigid endoscope. Suitable for small to medium central perforations with adequate canal width. Avoids a post-auricular incision and offers faster recovery.
• Post-auricular (retroauricular): The most versatile approach. A curved incision is made behind the auricle, providing excellent visualisation of the entire TM and middle ear. Preferred for large, anterior, or subtotal perforations and for concurrent ossicular work.
• Endoscopic transcanal tympanoplasty: A growing technique using 3 mm rigid endoscopes (0° and 45°). Offers superior visualisation of anterior recesses and the protympanum without canal canalplasty. Emerging evidence shows comparable graft success rates to microscopic surgery with reduced post-operative pain.

Graft Techniques

• Underlay (medial graft): The graft is tucked medially beneath the TM remnant and annulus. It is stabilised by absorbable gelfoam packing in the middle ear and external canal. This is the predominant technique globally, with graft take rates of 85–95%.
• Overlay (lateral graft): The squamous epithelium is stripped from the TM remnant and the graft placed laterally. Risk of blunting (anterior sulcus obliteration) requires meticulous technique but may be unavoidable in large anterior perforations.
• Cartilage tympanoplasty: Tragal or conchal cartilage (with or without perichondrium) provides a rigid, resistant graft. Used for large perforations, poor ET function, retraction pockets, and revision surgery. Reported graft success exceeds 90% in high-risk ears.

Graft Materials

Temporalis fascia remains the graft of first choice due to its availability, thinness, and ease of harvest. Perichondrium from the tragus provides similar properties. Cartilage composite grafts are reserved for complex cases. Synthetic materials (e.g., AlloDerm) have been used but offer no advantage over autograft in current literature.

Successful tympanoplasty delivers significant anatomical and functional benefits that improve quality of life across multiple domains.

Hearing Improvement

The primary functional outcome is reduction of the air-bone gap (ABG). Following successful myringoplasty (type I), patients can expect closure of the ABG to within 10–20 dB in approximately 80% of cases. Residual gap of <20 dB is generally sufficient for normal conversational hearing without amplification. Hearing gains are typically measurable within 6–8 weeks as the middle ear stabilises and packing absorbs.

Elimination of Recurrent Ear Discharge

An intact TM eliminates the portal through which respiratory pathogens access the middle ear and mastoid. Patients who previously experienced frequent episodes of ear discharge requiring topical antibiotic treatment gain freedom from these infections, with corresponding reduction in antibiotic use and healthcare visits.

Water Activity Clearance

Once healing is confirmed (typically at 3 months), patients can resume swimming, water sports, and showering without ear protection — activities restricted by an open perforation. This has particular quality-of-life impact in children and younger adults.

Prevention of Progressive Damage

Closing a perforation early prevents long-term sequelae of chronic middle-ear inflammation, including ossicular erosion, tympanosclerosis, cholesteatoma formation from retraction pockets, and sensorineural hearing loss from cochlear toxicity of chronic suppurative discharge.

Bilateral Staging Considerations

When both ears require surgery, staged procedures (typically 3–6 months apart) allow the first ear to heal and hearing to be confirmed before operating on the second ear, maintaining binaural hearing throughout the treatment course.

Patient-reported outcome measures (PROMs) consistently show improvements in social participation, occupational function, and psychological wellbeing following successful tympanoplasty, particularly in children where hearing restoration supports language development and educational attainment.

Tympanoplasty is generally a low-risk procedure but patients must be informed of both common and serious potential complications before consenting to surgery.

Common (1–10%)

• Graft failure / re-perforation: The most frequent complication. Risk is higher in large perforations, poor ET function, revision surgery, active infection, and children under 8. Requires observation or re-operation.
• Hearing not improved: Patients should be counselled that in approximately 10–15% of cases hearing improvement is minimal, particularly if sensorineural loss underlies the conductive deficit.
• Tinnitus: May be temporarily exacerbated post-operatively; usually resolves as the middle ear settles.
• Ear canal stenosis (blunting): More common with overlay technique; anterior sulcus scarring narrows the canal, requiring further surgery.

Uncommon (0.1–1%)

• Sensorineural hearing loss (SNHL): Inner ear trauma from instrumentation or from surgical manipulation of the ossicular chain, particularly the stapes. Risk is low (<1%) but potentially permanent.
• Tympanosclerosis of graft: Calcification of the healed TM occurs in a minority and rarely affects hearing significantly.
• Chorda tympani nerve injury: The nerve supplying taste to the anterior two-thirds of the tongue traverses the middle ear. Retraction or division during surgery can cause metallic taste or taste disturbance, usually transient but occasionally permanent.
• Facial nerve injury: Extremely rare (<0.1%); the facial nerve runs in a bony canal through the middle ear and is at risk only in revision or complex cases where anatomy is distorted.

Rare but Serious

• Perilymph fistula from stapedial footplate injury
• Cholesteatoma formation in the graft (epidermisation)
• Intracranial extension of infection (meningitis, brain abscess) — extremely rare in an otherwise healthy ear

Patients should report any sudden hearing loss, severe vertigo, facial weakness, or signs of deep wound infection (swelling, pus, fever) immediately after discharge.

Post-operative management is as important as the surgery itself. Strict adherence to instructions protects the healing graft during the critical first weeks.

Immediate Post-Operative Period (Week 1–2)

Patients are discharged with the external canal packed with absorbable gelfoam and a small cotton wool ball in the meatus. A head bandage is applied for 24 hours. Pain is typically mild and managed with paracetamol ± ibuprofen. Patients should keep the ear completely dry — no showering water in the ear, no swimming, and no forceful nose-blowing (which raises nasopharyngeal pressure and stresses the ET and graft). Sneezing with the mouth open is advised.

First Clinic Review (Week 2–3)

Non-absorbable sutures are removed if a post-auricular approach was used. The external canal packing is inspected and partially cleared. The graft is assessed for vascularity (a pink, opaque appearance indicates viable take). Otoscopy and microsuction are performed gently.

Graft Assessment (Week 6–8)

Most canal packing has absorbed by this stage. The graft is assessed for full incorporation. Pure-tone audiometry is performed to document hearing improvement. If the graft is fully healed, cautious showering (with a cotton-wool plug lightly lubricated with Vaseline) may be permitted.

Final Assessment (Month 3)

Full audiometry including tympanometry is performed. A type A tympanogram (normal compliance) confirms an intact, aerated middle ear. Patients are cleared for water activities including swimming if the TM is fully healed. Most patients are discharged from follow-up at 6 months with instructions to return if new symptoms arise.

Children require audiological monitoring for 12–18 months post-operatively given the risk of recurrent otitis media affecting the healed TM during the school-age years.

The cost of tympanoplasty varies substantially based on country, hospital accreditation status, surgical complexity, and whether it is performed as a day case or with overnight admission.

Approximate Cost Ranges by Region

• United States: USD 8,000–20,000 (without insurance; complex cases higher)
• United Kingdom (private): GBP 3,500–7,000
• India (accredited hospitals): USD 1,200–3,500 (type I–II); USD 2,500–5,000 (type III–V with ossicular work)
• Thailand: USD 2,000–5,000
• Turkey: USD 2,500–5,000
• Singapore: USD 4,000–9,000

Key Cost Drivers

• Wullstein type: Simple myringoplasty (type I) costs significantly less than tympanoplasty with ossiculoplasty (types II–IV).
• Surgical approach: Endoscopic procedures may carry a premium for equipment use.
• Revision surgery: Always more complex and expensive than primary procedures.
• Anaesthesia type: General anaesthesia adds cost compared to local with sedation.
• Pre-operative workup: High-resolution CT of temporal bones (HRCT) adds USD 200–800 if required.
• Surgeon expertise: Otologists with subspecialty fellowship training in otology/neurotology typically charge higher fees but achieve better outcomes in complex cases.

When seeking treatment abroad, patients should verify surgeon credentials (ENT or otolaryngology specialist with otology subspecialisation), hospital accreditation (JCI or NABH), and confirm that the quote includes pre-operative audiometry, HRCT if required, all surgical fees, anaesthesia, hospital stay, and at least two post-operative follow-up visits.

Not all tympanic membrane perforations require immediate surgical repair. A range of conservative and minimally invasive alternatives exist, though each has important limitations.

Watchful Waiting

Traumatic perforations (particularly those from slap injuries or cotton-bud trauma) close spontaneously in 85–90% of cases within 4–12 weeks. During this period, the ear must be kept dry and topical or systemic antibiotics administered only if secondary infection develops. Patients should be re-assessed at 3 months; non-healing perforations at this point are unlikely to close without intervention.

Paper Patch Myringoplasty

A temporising office-based technique in which a small paper or gelfoam patch is applied over the perforation under microscopy after freshening the edges. May stimulate healing in small, central perforations but success rates rarely exceed 50% and the procedure may need repeating. Unsuitable for large or marginal perforations.

Fat Myringoplasty

Injection of autologous fat (harvested from the earlobe) into a small perforation under local anaesthesia in an outpatient setting. Success rates of 70–80% for small (<30% of TM area) central perforations have been reported. Less suitable for large or anterior perforations requiring direct visualisation.

Hearing Aids

For patients who are not surgical candidates (advanced age, significant comorbidity, only-hearing ear, severe ET dysfunction), appropriately fitted hearing aids — particularly bone-anchored hearing aids (BAHAs) in cases of mixed or bilateral loss — can compensate effectively for the conductive component of hearing loss without the risks of surgery.

Eardrum Patches (Commercial)

Biologically active scaffolds (e.g., EpiDisc, synthetic collagen matrices) placed in office under anaesthesia are under investigation. Early-phase data show promise for small to medium perforations but long-term comparative data versus surgery are not yet available. These are not yet standard of care.